[Edaily Reporter Kwon Oh Seok ] The stock price of KODI Co.,LTD.(080530), a company specializing in color cosmetics, is surging in early trading. It appears that buying interest is surging following news that the company has resolved its overhang issue. (Photo courtesy of KODI Co.,LTD.) According to MP Doctor on the 11th, as of 9:16 a.m., KODI Co.,LTD.’s stock is trading at 2,665 won, up 13.62% from the previous trading day. Previously, the company announced in a regulatory filing the previous day, “We have fully repaid the remaining balance of 4.55 billion won on the 17th Series Convertible Bonds with Warrants (BW), issued on August 9, 2023.” The BWs redeemed this time are non-separable BWs, meaning the stock subscription rights expire simultaneously with the redemption of the bonds. The company expects that this full redemption will eliminate a potential overhang factor, alleviate market concerns regarding shareholder value dilution, and serve as a foundation for strengthening the company’s capital structure. A KODI Co.,LTD. official explained, “Since this repayment was carried out using the company’s own cash reserves without external financing, it demonstrated the company’s robust cash generation capacity and financial soundness to the market; from a financial management perspective, it also serves as a strategic measure to enhance shareholder value.”
Shares of Lunit and DRTECH rose on November 13 as improving financial performance attracted investor interest. Lunit gained on revenue growth and narrowing operating losses, while DRTECH benefited fro…
On the 13th, in the pharmaceutical and biotech sector, shares of Lunit Inc.(328130)and DRTECH Corporation(214680)rose in tandem, driven by improved earnings. Lunit Inc. attracted investor interest due…
Even as it has become increasingly difficult for biotech startups to secure funding, there are venture capital (VC) firms that remain active in biotech investments. One such firm is Pathway Partners (…